Compounds > vx 497
Page last updated: 2024-09-04

vx 497 and loperamide

vx 497 has been researched along with loperamide in 1 studies

Compound Research Comparison

Studies
(vx 497)		Trials
(vx 497)		Recent Studies (post-2010)
(vx 497)		Studies
(loperamide)		Trials
(loperamide)		Recent Studies (post-2010) (loperamide)
25371,358196488

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)loperamide (IC50)
Cocaine esteraseHomo sapiens (human)5.7
Beta-2 adrenergic receptorHomo sapiens (human)3.005
ATP-dependent translocase ABCB1Homo sapiens (human)2.5
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 29.27
Cytochrome P450 2D6Homo sapiens (human)2
Histamine H2 receptorHomo sapiens (human)3.081
Sodium-dependent serotonin transporterHomo sapiens (human)2.202
Mu-type opioid receptorHomo sapiens (human)0.0014
D(3) dopamine receptorHomo sapiens (human)1.337
Delta-type opioid receptorHomo sapiens (human)0.896
Kappa-type opioid receptorHomo sapiens (human)3.125
5-hydroxytryptamine receptor 2BHomo sapiens (human)4.105
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.033
Sodium channel protein type 5 subunit alphaHomo sapiens (human)0.239
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.628

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and loperamide

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023